Related Experiment Videos

Rationale for combination therapy in hypertension management: focus on angiotensin receptor blockers and thiazide

David T Nash1

  • 1State University of New York Upstate Medical University, Syracuse Preventive Cardiology Center, Syracuse, NY 13202, USA. davidtnash@aol.com

Southern Medical Journal
|April 27, 2007
PubMed

Insights

Achieving blood pressure control is crucial for reducing cardiovascular risks. Combining diuretics with renin-angiotensin system blockers offers an effective hypertension management strategy with potential for better adherence.

Area of Science:

  • Cardiology
  • Pharmacology
  • Public Health

Background:

  • Hypertension is a significant risk factor for cardiovascular events and mortality.
  • Current blood pressure control rates in the US remain suboptimal.
  • Guidelines recommend multiple antihypertensive medications for effective blood pressure management.

Purpose of the Study:

  • To highlight the efficacy of combination therapy in hypertension management.
  • To emphasize the benefits of combining diuretics with renin-angiotensin system (RAS) blockers.
  • To discuss the potential for improved treatment adherence with combination therapy.

Main Methods:

  • Review of clinical trial results and hypertension management guidelines.
  • Analysis of the mechanisms of action for complementary antihypertensive drug combinations.
  • Evaluation of the safety and efficacy profiles of specific drug combinations.

Main Results:

  • Combination therapy, particularly diuretics with RAS blockers, demonstrates high efficacy in lowering blood pressure.
  • This combination therapy shows a favorable side effect profile comparable to monotherapy.
  • RAS-blocking agents are associated with a reduced risk of new-onset diabetes mellitus.

Conclusions:

  • Well-designed antihypertensive drug combinations offer an efficient and effective approach to hypertension management.
  • Combining low-dose diuretics with RAS blockers is a clinically beneficial strategy.
  • Improved efficacy and potentially lower adverse events can enhance patient adherence to treatment.

Related Concept Videos

Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Antihypertensive Drugs: Angiotensin II Receptor Blockers01:30

Antihypertensive Drugs: Angiotensin II Receptor Blockers

In the renin-angiotensin-aldosterone system, a hormone called angiotensin II plays a crucial role. It binds to the AT1 receptors in vascular smooth muscles coupled with Gq proteins. The activation of these receptors activates an enzyme called phospholipase C, which releases two molecules: inositol trisphosphate and diacylglycerol. These molecules cause a chain reaction that leads to the phosphorylation of myosin light chains and promotes interaction between actin and myosin, leading to smooth...
Antihypertensive Drugs: Thiazide-Class Diuretics01:15

Antihypertensive Drugs: Thiazide-Class Diuretics

Thiazide diuretics are sulfonamide derivatives featuring a benzothiadiazine ring system in their molecular structure. Based on this structure, thiazide diuretics can be categorized into two groups: thiazide-type and thiazide-like diuretics. Thiazide-type diuretics, including hydrochlorothiazide and chlorothiazide, consist of a benzothiadiazine backbone with an attached sulfonamide group. Thiazide-like diuretics, such as chlorthalidone and indapamide, lack the thiazide ring but demonstrate...
Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors01:30

Antihypertensive Drugs: Angiotensin-Converting Enzyme Inhibitors

Angiotensin-converting enzyme (ACE), a vital component of the renin-angiotensin-aldosterone system, is abundant in lung endothelial cells. ACE converts the inactive decapeptide, angiotensin I, into the active octapeptide, angiotensin II. This potent vasoconstrictor narrows blood vessels, increasing resistance to blood flow and elevating blood pressure. Angiotensin II also stimulates aldosterone production, encouraging kidney cells to reabsorb more sodium and water from urine, thereby increasing...